長虹佳華(03991.HK)擬夥申萬宏源(06806.HK)等組合夥企業投資新能源等領域
長虹佳華(03991.HK)公佈,董事會已決議通過批準間接全資附屬長虹佳華數字與公司控股股東四川長虹電子控股及四川長虹(600839.SH),以及申萬宏源(06806.HK)及其各自附屬成立合夥企業。
合夥企業之初步出資總額將不少於15億元人民幣(下同),其中長虹佳華數字擬出資3,000萬,佔合夥企業的股權比例爲2%。合夥企業之投資範圍將主要集中於具有高增長潛力並從事新能源、半導體、信息技術應用創新產業、智慧家庭及智能製造等領域。如獲落實,各合夥人後續將簽署合夥協議。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.